Princeton Global Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Princeton Global Asset Management's BMY Position: Q2 2026 in Review

Princeton Global Asset Management increased its Bristol-Myers Squibb (BMY) stake by 2.4% in Q2 2026, buying an estimated $4.65K and bringing the position to 3,450 shares worth $199K. The position accounts for 0.03% of the portfolio, ranked #219.

Princeton Global Asset Management first reported a position in BMY in Q4 2018 and has held it in 31 quarters since. The position peaked at $3.24M in Q1 2023. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

• Princeton Global Asset Management held 3,450 shares of Bristol-Myers Squibb worth $199K as of Q2 2026.
• Princeton Global Asset Management bought 81 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.65K.
• Bristol-Myers Squibb made up 0.03% of Princeton Global Asset Management's portfolio in Q2 2026, its #219 holding.
• Princeton Global Asset Management first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 31 quarters since.
• Princeton Global Asset Management's Bristol-Myers Squibb position peaked at $3.24M in Q1 2023.
• 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Princeton Global Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.